Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
21.58
+0.24 (1.12%)
Aug 21, 2026, 3:36 PM EDT - Market open
Anika Therapeutics Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 120.65 | 112.82 | 119.91 | 120.79 | 113.83 | 147.79 |
Revenue Growth | 5.33% | -5.91% | -0.73% | 6.12% | -22.98% | 13.29% |
Gross Profit Gross Profit Growth | 75 | 63.81 | 76.6 | 82.53 | 73.22 | 89.41 |
Operating Income Operating Income Growth | -2.59 | -11.05 | -4.5 | 0.84 | 3.67 | -12.02 |
Net Income Net Income Growth | -3.78 | -10.88 | -56.39 | -82.67 | -14.86 | 4.13 |
Earnings Per Share EPS Growth | -0.28 | -0.76 | -3.83 | -5.64 | -1.02 | 0.28 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | 74.11 | 70.06 | 82.45 | 86.91 | 83.75 | 113.83 |
Europe Europe Growth | 25.17 | 22.21 | 19.4 | 17.31 | 17.23 | 19.58 |
Other Other Growth | 21.38 | 20.55 | 18.06 | 16.57 | 12.85 | 14.38 |
Total Total Growth | 120.65 | 112.82 | 119.91 | 120.79 | 113.83 | 147.79 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 38.41 | 57.48 | 55.63 | 68.74 | 86.33 | 94.39 |
Total Debt Total Debt Growth | 25.25 | 26.25 | 25.93 | 27.74 | 30.89 | 20.95 |
Net Cash (Debt) Net Cash Growth | 13.16 | 31.23 | 29.7 | 41 | 55.44 | 73.43 |
Net Cash Growth | -53.29% | 5.17% | -27.57% | -26.05% | -24.51% | -3.19% |
Net Cash Per Share Net Cash Per Share Growth | 0.95 | 2.18 | 2.02 | 2.80 | 3.81 | 5.02 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 5.98 | 11.19 | 5.4 | -1.79 | 4.41 | 8.4 |
Capital Expenditures CapEx Growth | -5.42 | -6.83 | -7.73 | -5.43 | -7.49 | -5.14 |
Free Cash Flow Free Cash Flow Growth | 0.56 | 4.36 | -2.33 | -7.22 | -3.08 | 3.25 |
Free Cash Flow Growth | - | - | - | - | - | -71.55% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 62.17% | 56.56% | 63.89% | 68.33% | 64.33% | 60.49% |
Operating Margin | -2.15% | -9.79% | -3.75% | 0.70% | 3.22% | -8.13% |
Pretax Margin | -2.41% | -8.25% | -2.31% | 2.61% | 3.80% | 1.64% |
Profit Margin | -3.14% | -9.64% | -47.02% | -68.44% | -13.05% | 2.80% |
FCF Margin | 0.47% | 3.87% | -1.94% | -5.97% | -2.70% | 2.20% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 125.13 |
Forward PE | 24.33 | 53.39 | 39.19 | 72.08 | 72.08 | 112.55 |
P/FCF Ratio | 508.17 | 31.77 | - | - | - | 158.96 |
PS Ratio | 2.37 | 1.23 | 2.01 | 2.75 | 3.80 | 3.50 |